Earnings Feed
Start Free
Syros Pharmaceuticals, Inc.·4

Nov 20, 5:00 PM ET

Stephens Kristin 4

4 · Syros Pharmaceuticals, Inc. · Filed Nov 20, 2024

Insider Transaction Report

Form 4
Period: 2024-11-18
Syros Pharmaceuticals, Inc.SYRS
Stephens Kristin
Chief Development Officer
Transactions
  • Sale

    Common Stock

    2024-11-18$0.22/sh−36,133$7,949→ 0 total

Documents

1 file
  • 4
    ownership.xmlPrimary

    4